[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU7906998A - Compounds with growth hormone releasing properties - Google Patents

Compounds with growth hormone releasing properties

Info

Publication number
AU7906998A
AU7906998A AU79069/98A AU7906998A AU7906998A AU 7906998 A AU7906998 A AU 7906998A AU 79069/98 A AU79069/98 A AU 79069/98A AU 7906998 A AU7906998 A AU 7906998A AU 7906998 A AU7906998 A AU 7906998A
Authority
AU
Australia
Prior art keywords
compounds
growth hormone
hormone releasing
releasing properties
properties
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU79069/98A
Inventor
Michael Ankersen
Thomas Kruse Hansen
Nils Langeland Johansen
Jesper Lau
Kjeld Madsen
Bernd Peschke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU7906998A publication Critical patent/AU7906998A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU79069/98A 1997-06-20 1998-06-12 Compounds with growth hormone releasing properties Abandoned AU7906998A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK725/97 1997-06-20
DK72597 1997-06-20
PCT/DK1998/000249 WO1998058950A1 (en) 1997-06-20 1998-06-12 Compounds with growth hormone releasing properties

Publications (1)

Publication Number Publication Date
AU7906998A true AU7906998A (en) 1999-01-04

Family

ID=8096826

Family Applications (1)

Application Number Title Priority Date Filing Date
AU79069/98A Abandoned AU7906998A (en) 1997-06-20 1998-06-12 Compounds with growth hormone releasing properties

Country Status (5)

Country Link
EP (1) EP1005484A1 (en)
JP (1) JP4116097B2 (en)
AU (1) AU7906998A (en)
WO (1) WO1998058950A1 (en)
ZA (1) ZA985278B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083908A (en) * 1998-01-16 2000-07-04 Novo Nordisk A/S Compounds with growth hormone releasing properties
KR20010034198A (en) * 1998-01-16 2001-04-25 한센 핀 베네드 Compounds with growth hormone releasing properties
MY153569A (en) 1998-01-20 2015-02-27 Mitsubishi Tanabe Pharma Corp Inhibitors of ?4 mediated cell adhesion
US6919315B1 (en) 1998-06-30 2005-07-19 Novo Nordisk A/S Compounds with growth hormone releasing properties
AU771644B2 (en) * 1998-06-30 2004-04-01 Helsinn Healthcare Sa Compounds with growth hormone releasing properties
EP1930021A3 (en) 1999-02-18 2008-06-18 Kaken Pharmaceutical Co., Ltd. Novel amide derivatives as growth hormone secretagogues
JP4644402B2 (en) * 1999-07-26 2011-03-02 ベイラー カレッジ オブ メディスン Ultra high activity porcine growth hormone releasing hormone analog
ES2333097T3 (en) 2000-05-31 2010-02-17 Raqualia Pharma Inc USE OF SECRETAGOGS OF GROWTH HORMONE TO STIMULATE GASTROINTESTINAL MOTILITY.
PL374971A1 (en) 2002-08-09 2005-11-14 Transtech Pharma, Inc. Aryl and heteroaryl compounds and methods to modulate coagulation
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
WO2005014532A1 (en) 2003-08-08 2005-02-17 Transtech Pharma, Inc. Aryl and heteroaryl compounds, compositions and methods of use
US7208601B2 (en) 2003-08-08 2007-04-24 Mjalli Adnan M M Aryl and heteroaryl compounds, compositions, and methods of use
CU23558A1 (en) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech COMPOUNDS ANALOG TO THE PEPTIDIC SECRETAGOGS OF THE GROWTH HORMONE
CN101657436A (en) 2007-02-09 2010-02-24 特兰齐姆制药公司 Macrocyclic ghrelin receptor modulators and using method thereof
US9119832B2 (en) 2014-02-05 2015-09-01 The Regents Of The University Of California Methods of treating mild brain injury
WO2017075535A1 (en) 2015-10-28 2017-05-04 Oxeia Biopharmaceuticals, Inc. Methods of treating neurodegenerative conditions

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1175810A (en) 1979-03-30 1984-10-09 Frank A. Momany Synthetic peptides having pituitary growth hormone releasing activity
WO1983002272A1 (en) 1981-12-28 1983-07-07 Beckman Instruments Inc Synthetic peptides having pituitary growth hormone releasing activity
US4839344A (en) 1987-06-12 1989-06-13 Eastman Kodak Company Polypeptide compounds having growth hormone releasing activity
US4817283A (en) 1987-08-21 1989-04-04 Amp Incorporated Method of forming a modular plug coupler
EP0400051B1 (en) 1988-01-28 1995-05-10 Polygen Holding Corporation Polypeptide compounds having growth hormone releasing activity
DE68912775T2 (en) 1988-05-11 1994-06-30 Polygen Holding Corp POLYPEPTIDE COMPOUNDS WITH HORMONE GROWTH RELEASING EFFECT.
IT1240643B (en) 1990-05-11 1993-12-17 Mediolanum Farmaceutici Spa BIOLOGICALLY ACTIVE PEPTIDES CONTAINING IN 2-ALCHYL TRIPTOFANE CHAIN
IL98910A0 (en) 1990-07-24 1992-07-15 Polygen Holding Corp Polypeptide compounds having growth hormone releasing activity and pharmaceutical compositions containing them
US5663146A (en) 1991-08-22 1997-09-02 Administrators Of The Tulane Educational Fund Polypeptide analogues having growth hormone releasing activity
AU684878B2 (en) 1993-11-24 1998-01-08 Merck & Co., Inc. Compounds and the use thereof to promote the release of growth hormone(s)
WO1995017422A1 (en) 1993-12-23 1995-06-29 Novo Nordisk A/S Compounds with growth hormone releasing properties
BR9408377A (en) 1993-12-23 1997-08-19 Novo Nordisk As Compound pharmaceutical composition process to stimulate the release of pituitary growth hormone and use of the compound
US5798337A (en) * 1994-11-16 1998-08-25 Genentech, Inc. Low molecular weight peptidomimetic growth hormone secretagogues
CZ238197A3 (en) 1995-01-27 1997-12-17 Novo Nordisk As Growth hormone formation stimulating compounds
BR9608909A (en) 1995-06-22 1999-03-02 Novo Nordisk As Compound pharmaceutical composition processes to stimulate the release of growth hormone from patuitaria and increase the speed and extent of growth of animals to increase milk or wool production of animals or for diseases and use of the compound
CA2239711A1 (en) 1995-12-22 1997-07-03 Novo Nordisk A/S Compounds with growth hormone releasing properties
JP4425992B2 (en) * 1996-07-22 2010-03-03 サファイア セラピューティクス，インコーポレイティド Compounds with growth hormone releasing properties

Also Published As

Publication number Publication date
WO1998058950A1 (en) 1998-12-30
JP4116097B2 (en) 2008-07-09
ZA985278B (en) 1999-01-19
EP1005484A1 (en) 2000-06-07
JP2002505677A (en) 2002-02-19

Similar Documents

Publication Publication Date Title
HUP9802580A3 (en) Compounds with growth hormone releasing properties
AU2546399A (en) Preparations with controlled release
IL122371A0 (en) Compounds with growth hormone releasing properties
AU2465899A (en) Prostheses with associated growth factors
AU7906998A (en) Compounds with growth hormone releasing properties
AU2382097A (en) Compounds with growth hormone releasing properties
AU4534596A (en) Compounds with growth hormone releasing properties
AU3687297A (en) Insecticidal composition
AU5671099A (en) Compounds having growth hormone releasing activity
AU4534696A (en) Compounds with growth hormone releasing properties
AUPP243898A0 (en) Two-part clip
AU2686899A (en) Growth hormone secretagogues
ZA96544B (en) Compounds with growth hormone releasing properties
ZA965279B (en) Compounds with growth hormone releasing properties
ZA9610775B (en) Compounds with growth hormone releasing properties
ZA973483B (en) Compounds with growth hormone releasing properties.
AU5527296A (en) Growth factor htter36
ZA9410262B (en) Compounds with growth hormone releasing properties
AUPP582198A0 (en) Modified human growth hormone
ZA99238B (en) Compounds with growth hormone releasing properties.
ZA200005820B (en) Compounds with growth hormone releasing properties.
AUPO495497A0 (en) Growth factors
AUPO743597A0 (en) Growth factor
AUPP113197A0 (en) Growth factor
AU2419097A (en) Use of growth hormone

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase